Aspiriant LLC’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-7,226
| Closed | -$581K | – | 281 |
|
|
2022
Q3 | $581K | Buy |
7,226
+2
| +0% | +$161 | 0.03% | 157 |
|
|
2022
Q2 | $539K | Buy |
7,224
+80
| +1% | +$5.97K | 0.03% | 161 |
|
|
2022
Q1 | $913K | Sell |
7,144
-156
| -2% | -$19.9K | 0.05% | 138 |
|
|
2021
Q4 | $980K | Buy |
+7,300
| New | +$980K | 0.05% | 137 |
|